Notícias Aditxt Inc - ADTX | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Aditxt Inc (ADTX)
Aditxt Inc (ADTX) Notícias

Aditxt Inc (ADTX)

0,056

0,0062

( 12,45% )

Atualizado: 17:04:12

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

Sylvia Hermina Joins Aditxt’s Board of Directors, Elevating Leadership with Broader Perspectives

Aditxt Completes Final Equity Investment and Key Milestone Under the Amended and Restated Merger Agreement with Evofem

Form 424B5 - Prospectus [Rule 424(b)(5)]

Aditxt to Host a Virtual Fireside Chat with Aditxt CEO Amro Albanna and Evofem CEO Saundra Pelletier, Moderated by MD & Media Personality Dr. Drew Pinsky, on October 28, 2024, at 11:30 AM Eastern Time

Form 8-K - Current report

Aditxt’s Acquisition Target Appili Therapeutics Will Hold a Special Meeting of Shareholders on November 6, 2024, to Vote on the Transaction and Secure Appili’s Shareholder Approval

Form 8-K - Current report

Aditxt To Host Stakeholder Update and Q&A Session on Friday, October 11, 2024, at 11:30 AM Eastern Daylight Time

Aditxt Completes Third Parent Equity Investment Under Amended and Restated Merger Agreement With Evofem

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 8-K - Current report

Aditxt Delivers Shareholder Update and 2024 Year-End Plan

Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on October 2, 2024

Evofem Biosciences Files Preliminary Proxy for Stockholder Approval of the Acquisition by Aditxt

1
2
3
Próxima

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições